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In this study cyclophosphamide was used to prepare the blood-deﬁcient model. The red blood cell count and hemoglobin content
were measured. The experimental chickens presented the symptoms of blood-deﬁcient syndrome, dullness, shrinkinginto oneself,
broken winded, loose feather, waxy eyelid, and pale tongue. At the same time, red blood cell count and hemoglobin content
decreased signiﬁcantly. Angelica polysaccharide as the eﬀective component of Angelica Sinensis could signiﬁcantly increase the
red blood cell count and the hemoglobin content of blood-deﬁcient chickens. The results indicated that cyclophosphamide could
signiﬁcantly reduce the red blood count and hemoglobin content, and make the ideal blood-deﬁcient model successfully. Angelica
polysaccharide had the function of enriching blood in diﬀerent ways. On the one hand Angelica polysaccharide enriched he blood
directly, increased the number of RBC and hemoglobin; on the other hand it regulated the hematopoietic factors, enriched the
blood indirectly.
1.Introduction
Based on the traditional Chinese veterinary medicine, syn-
drome of blood deﬁciency is a morbid condition of insuf-
ﬁcient blood supply to the visceral organs and channels for
their nutrition due to improper feeding, malnutrition, pro-
fuse bleeding, chronic hemorrhage, or diminished produc-
tion of blood on account of hypofunction of the internal
organs. The main manifestations are pale tongue, dullness,
sparse hair, thready-weak pulse, and so forth [1]. Animal
experimental study is an indispensable way to illustrate the
etiology and pathogenesis of blood-deﬁcient syndrome.
Likewise, animal experiment is a method to study the
mechanismofhematinicsontreatingdeﬁciencyofblood.An
animal model of blood-deﬁcient syndrome is an important
step in the research on the modernization of traditional
Chinese veterinary medicine [2]. Angelica Sinensis, known
as Danggui in China, is one of the most popular traditional
Chinese medicines as blood-enriching drugs. The medicinal
part is composed of its dried roots with sweet-acrid taste,
warm property, and attribution to the heart, liver and
spleen channels. It is commonly used to enrich or nourish
blood and activate blood circulation. Angelica Sinensis is
contained by more than 80 composite formulae. Modern
researches indicate that phthalides, organic acids, and their
esters, polysaccharides are the main chemical components
related to the bioactivities and pharmacological properties
of Danggui [3–5]. Angelica polysaccharide is water-soluble
organic compound extracted from the root of Angelica
Sinensis.Angelicapolysaccharide,astheeﬀectivecomponent
of Angelica Sinensis in enriching blood, has the eﬃcacy of
purifying blood quality, emmenagogue, acesodyne, lenitive,
improving circulation and immunity, antiviral, antitumor,
antioxidation, and so forth [6–9]. It is used frequently in
clinics and also frequently appears as the main ingredient
in prescriptions for bone injures. Cyclophosphamide is a
cytostatic agent that produces systemic toxicity especially
on cells with high proliferative capacity, while polysaccha-
rides from Angelica polysaccharide have been shown to
increase the turnover of hemopoietic stem cells [10]. In the
modern society Angelica polysaccharide has a better poten-
tial for drug development [11]. Previous research showed
Angelica polysaccharide had eﬀects on enriching blood in
mice/human with blood deﬁciency [10, 12]. However, there’s2 Evidence-Based Complementary and Alternative Medicine
less reports on its hematopoiesis of Angelica polysaccharide
about poultry. In this study, Cyclophosphamide was used
to investigate whether the blood-deﬁcient model was suc-
cessfully made in chickens, at the same time to discuss the
mechanisms on enriching and nourishing blood of Angelica
polysaccharide [12–16].
2.MaterialsandMethods
2.1. Animals. One-day-old Hyline Brown chickens (male)
werepurchasedfromHebeilaboratoryanimalcenter,housed
in cages and lighted for 24h at the beginning of pretrial
period. The chicks were given free access to feedstuﬀ and
water.
2.2. Reagent. Angelica polysaccharide was purchased from
Beijing Biochem Co., Ltd. China. Cyclophosphamide was
purchased from Jiangsu Hengrui Medicine Co., Ltd (no.
06121021).
2.3. Grouping and Treatment. Eighty 14-day-old normal
chickens were randomly divided into eight groups with the
same number and similar body weight. Angelica polysac-
charide (1%) diluted with distilled water was drenched to
the chickens by oral administration in a sterile syringe
without a needle. The healthy chickens in group I as control,
the healthy chickens in group II, III, and IV were given
three gradient dosages (50mg/Kg, 100mg/Kg, 150mg/Kg)
of Angelica polysaccharide, respectively, for 7 days. Chickens
in group V, VI, VII, and VIII were given Cyclophosphamide
by intraperitoneal injection, 6 days later the blood-deﬁcient
chicken model was made. After the blood-deﬁcient chicken
model was set up, chickens in group VI, VII, and VIII
were given three gradient dosages (50mg/Kg, 100mg/Kg,
150mg/Kg) of Angelica polysaccharide, respectively, for 7
days.Alltheexperimentalanimalsweretreatedinaccordance
with the guidelines of the Chinese Council for Animal Care.
2.4. Blood Specimen Collection and Examination. Until the
last Angelica polysaccharide administration, the blood spec-
imens were collected from heart for red blood cells (test tube
method) and hemoglobin (turbidimetry) tests. The steps
were followed with [17].
2.5. Data Statistics. All data had a normal distribution
presented as mean ± standard deviation (SD) and analysed
by SPSS11.0 statistical software. Statistical signiﬁcance was
determined by one-way analysis of variance (ANOVA) fol-
lowed by student’s t-test. A probability of less than 0.01 was
considered to be statistically signiﬁcant.
3. Results
3.1. Symptoms. The blood-deﬁcient model was made by
intraperitoneal injection of Cyclophosphamide for 6 days
(80mg/Kg·d). 6 days later, the chickens behaved as follows:
dullness, shrinking into oneself, broken winded, loose-
feather, waxy eyelid, and pale tongue. It can be concluded
from the clinical manifestations that chicken for blood-
deﬁcient syndrome model has been successfully set up.
Healthy chickens given Angelica polysaccharide behaved as
follows, physical agility, pink tongue and bright feather. The
blood-deﬁcient chickens returned to the normal symptoms
aftergivenAngelicapolysaccharide.Blood-deﬁcientchickens
given Angelica polysaccharide had no notable changes than
the control group.
3.2. Eﬀects of Angelica Polysaccharide on
Blood Physiological Index
3.2.1. Eﬀects of Angelica Polysaccharide on the Red Blood Cell
Count. It showed in Table 1 that the red blood cell count in
group (II) had no more change than the control group (P>
0.05). Angelica polysaccharide in group (III) and (IV) had
signiﬁcant eﬀects on the red blood cell count than group I
(P<0.01).WhenthehealthychickensweregivenCyclophos-
phamide, there was a signiﬁcant decrease in the number of
erythrocyte in group V (P<0.0 1 ) .H o w e v e r ,a f t e rt h eb l o o d -
deﬁcient chickens were given Angelica polysaccharide, the
number of erythrocyte gradually increased. In added, the red
blood cell count in group VIII was notably higher than the
control (P<0.05). The number of erythrocyte in group VII
and VIII were signiﬁcantly higher than group V (P<0.01).
In a word, Cyclophosphamide can lead to the red blood cell
count reduction and Angelica polysaccharide as hematinic
can increase it.
3.2.2. Eﬀects of Angelica Polysaccharide on Hemoglobin Con-
tent. It showed in Table 2 that hemoglobin content in group
II had no more change than the control group (P>0.05).
Angelica polysaccharide in group III and IV had signiﬁcant
eﬀects on hemoglobin content than group I (P<0.01).
When the healthy chickens were given Cyclophosphamide,
there was a signiﬁcant decrease in the hemoglobin con-
tent in group V (P<0.01). However, after the blood-
deﬁcient chickens were given Angelica polysaccharide, the
hemoglobin content gradually increased. The hemoglobin
content in group VII and VIII were signiﬁcantly higher
than group V (P<0.01). In a word, Cyclophosphamide
can lead to the hemoglobin content reduction and Angelica
polysaccharide as hematinic can increase it.
4. Discussion
At present many methods which have diﬀerent character-
istics could set up blood-deﬁcient animal model, such as
radiation damage method, chemical method, and immune
induce method [18]. Bleeding method which does not use
special equipment is simple, with deﬁnite index. Bleeding
method brings about the decrease of the peripheral blood
cells immediately; however, the bloodletting quantity is hard
to control and has little eﬀect on the hematopoietic system
of organism [19]. Radiation damage method which uses
60Co-γ to irradiate animals could damage bone marrow and
aﬀect the hematopoietic function. Radioactive ray has direct
damage to stem cells and bone marrow microenvironment.Evidence-Based Complementary and Alternative Medicine 3
Table 1: Eﬀects of Angelica polysaccharide on red blood cell count
in chickens.
Group N Dosage
(mg/kg)
Count of RBC
(×1012/L)
(I) Control of healthy
chicken 10 0 276.453 ±23.412

( I I )L o wd o s a g ei n
healthy chicken 10 50 279.579 ±25.890
(III) Middle dosage in
healthy chicken 10 100 312.132 ± 12.900∗∗
(IV) High dosage in
healthy chicken 10 150 313.256 ± 17.203∗∗
(V) CY 10 0 241.557 ± 14.498∗∗
(VI) CY with low
dosage 10 50 262.624 ±15.560
(VII) CY with middle
dosage 10 100 283.233 ±13.412

(VIII) CY with high
dosage 10 150 298.684 ±21.287∗

∗∗Superscript diﬀers signiﬁcantly (P<0.01) compared with group I,
∗superscript diﬀers notably (P<0.05) compared with group I. 
Superscript diﬀers signiﬁcantly (P<0.01) compared with group V, 
superscript diﬀers notably (P<0.05) compared with group V. CY stands
for Cyclophosphamide. RBC stands for red blood cell.
Table 2: Eﬀects of Angelica polysaccharide on hemoglobin content
in chickens.
Group N Dosage
(mg/kg)
Hemoglobin content
(g/L)
(I) Control of healthy
chicken 10 0 71.203 ±9.898

( I I )L o wd o s a g ei n
healthy chicken 10 50 77.316 ±2.493
(III) Middle dosage in
healthy chicken 10 100 84.611 ± 3.752∗∗
(IV) High dosage in
healthy chicken 10 150 86.684 ± 5.610∗∗
(V) CY 10 0 63.797 ± 3.337∗∗
(VI) CY with low
dosage 10 50 72.541 ±5.630
(VII) CY with middle
dosage 10 100 78.255 ±7.266

(VIII) CY with high
dosage 10 150 78.256 ±3.538

∗∗Superscript diﬀers signiﬁcantly (P<0.01) compared with group I,
∗superscript diﬀers notably (P<0.05) compared with group I. 
Superscript diﬀers signiﬁcantly (P<0.01) compared with group V, 
superscript diﬀers notably (P<0.05) compared with group V. CY stands
for Cyclophosphamide.
Radioactive ray brings down the bone marrow and aﬀects
CFU-E, BFU-E, and CFU-GM at certain dosage. Radiation
damage method needs to use special equipment, at the
same time the radiation dosage is diﬃcult to control. When
the radiation dosage is low it cannot meet the damage
requirement. Likewise, if the radiation dosage is high it may
lead to death [20].
As the chemical method, in this experiment Cyclophos-
phamide was used to make the blood-deﬁcient model
[21]. The dosage, route and times of Cyclophosphamide
administration were all easily to control by intraperitoneal
injection. Cyclophosphamide is a kind of nitrogen mustards
alkylating agent produced synthetically. Cyclophosphamide
which is a broad spectrum anti-tumor medicine is widely
used to treat acute/chronic lymphocytic leukemia, malignant
lymphoma, myelomatosis multiplex, and so forth. When
Cyclophosphamide got into animal body, it broke down
into chloroethyl phosphopeptamine with alkylating function
induced by hepatomicrosome P450 enzyme system. Then
chloroethyl phosphopeptamine led to single-strand and
double-strand DNA broken by cross-linking DNA strands.
As an antitumor drug, Cyclophphosphamide destroyed the
structure of DNA directly, interfered the transcription of
DNA, inhibited the synthesis of RNA and protein, thus
Cyclophosphamide prevented the proliferation of cell and
reduced the blood supply. So Cyclophosphamide caused
widespread destruction of hemopoietic system and immune
system [22, 23]. In clinic, the eﬀects of Cyclophosphamide
areperformedmainlyinimmunologicalfunctionrepression,
marrow inhibition and peripheral blood cell decrease [24,
25]. Experiments indicated Cyclophosphamide had obvious
inhibitive eﬀects on red cell immune function [26]. Studies
showed that Cyclophosphamide could also damage the
bone marrow microenvironment and the proliferation and
diﬀerentiation of hematopoietic cell, in order to inhibit the
hematopoietic function [23, 27]. The two inhibitive eﬀects
made the deﬁciency of blood.
In order to research the pathophysiological changes of
blood-deﬁcient syndrome, experimental index interrelated
with Ying blood function was chosen to examine [28].
Erythrocyte and hemoglobin could reﬂect the quantitative
andfunctionalchangesofblood-deﬁcientsyndrome.Thered
bloodcellcountandhemoglobincontentarebothimportant
standardstomeasure.Clinically,bloodlossandanemiaoften
present with the reduction of erythrocyte and hemoglobin
content [29–31]. Angelica Sinensis as the traditional Chinese
medicine is one of the most popular medicine to treat blood-
deﬁcientsyndrome,andAngelicapolysaccharideisthemajor
component of Angelica Sinensis in enriching blood. Recent
studies demonstrated that Angelica polysaccharide could
eﬀect the hemopoietic system of animal and had obvious
promoter action on proliferation and diﬀerentiation of
myelogenous hemopoietic progenitor cell of human and
rats. It was also reported that indicated Angelica polysac-
charide could increase C3b receptor rates, leucocyte and
thrombocyte in peripheral blood of mice with radiation-
injury remarkably. Likewise, Angelica polysaccharide could
improve the hemopoietic function of radiation injured mice
[32]. Studies showed that supernatant induced by Angelica
polysaccharide of bone marrow macrophage could increase
the colony-forming eﬃciency of myelogenous hemopoietic
progenitor cell. Induced by Angelica polysaccharide, protein
levels of EPO, GM-CSF, IL-3, and IL-6 expressed by bone
marrow macrophage were improved diﬀerently, at the same
time the expression levels and strength of mRNA of EPO
and GM-CSF were increased signiﬁcantly [33]. At the gene4 Evidence-Based Complementary and Alternative Medicine
level and protein level, Angelica polysaccharide promoted
the synthesis and excretion hemopoiesis regulatory factors
and then promoted the proliferation and diﬀerentiation of
hemopoietic progenitor cell. It can be seen that Angelica
polysaccharide not only supports the normal hemopoiesis
but also inhibits the proliferation of tumor cell such as
leukemia. It can be used for a natural revulsant. The
hematopoietic function of Angelica polysaccharide works in
diﬀerent ways. On the one hand Angelica polysaccharide
enriches he blood directly, increases the number of RBC and
hemoglobin; on the other hand it regulates the hematopoi-
etic factors, enriches the blood indirectly.
In this experiment the results indicated that Angelica
polysaccharide could improve the symptoms of blood-
deﬁcient syndrome made by Cyclophosphamide, at the
same time, signiﬁcantly increase the red blood cell count
and the hemoglobin content of blood-deﬁcient chickens.
With the development of scientiﬁc and technological and
traditional Chinese medicine theory, mechanism of Angelica
polysaccharide on enriching blood will be deepened and
systematized gradually.
5. Conclusion
This study suggests that Cyclophphosphamide can make
the ideal blood-deﬁcient model successfully by intraperi-
toneal injection for 6 days (80mg/Kg·d) when the chickens
were 14-day-old. The experimental chickens presented the
symptoms of blood-deﬁcient syndrome, dullness, shrinking
into oneself, broken winded, loose feather, waxy eyelid,
and pale tongue. At the same time, red blood cell count
and hemoglobin content decreased signiﬁcantly. This blood-
deﬁcient model remains the advantage of high survival rate
as well as long duration of blood-deﬁcient symptoms. The
results also show that Angelica polysaccharide can signif-
icantly increase the red blood cell count and hemoglobin
content of blood-deﬁcient chickens.
In conclusion, the blood-deﬁcient model made by
intraperitoneal injection of Cyclophphosphamide is more
suitable for the clinical manifestations. As the main compo-
nent of Angelica Sinensis, Angelica polysaccharide has the
function of enriching blood. The ﬁnding provides a better
basis for the clinic use of hematopoietic.
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